Reaction

Implant Site Mass reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 177 reports · 2 co-occurring drugs

As of the last recalculation, Implant Site Mass appears in 177 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL (PRR 591.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Etonogestrel102591.8593.1
Bupivacaine678.178.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.